Merck & Co has outlined its global plans following the completion of Merck’s merger with Schering-Plough Corporation.
The new Merck is aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.
Expanded portfolio
The new Merck’s expanded portfolio also includes leading products from its Animal Health and Consumer Health Care business units.
Merck’s Animal Health business is a world leader with market-leading products for a broad range of species and strong growth potential. The division has more than 1,000 marketed products and generates approx. $3 bln in revenues.
Organisational structure
During the past 6 months, Merck and Schering-Plough merger integration teams worked hard to successfully maintain the business momentum of the 2 companies while ensuring operational readiness and business continuity for the merged company.
Merck has 5 primary divisions: Global Human Health, Animal Health, Consumer Health Care, Merck Research Laboratories and Merck Manufacturing.